cbsnews.com — TRENTON, N.J. - Drugmaker Merck & Co., a pioneer in AIDS research, is licensing two experimental HIV drugs from other companies and advancing one of its own into mid-stage patient testing. Merck, based in Whitehouse Station, N.J., said Tuesday that it's signed one deal with Chimerix Inc.